clinical-virology-registration-950x250

Partner with us

Join us for two informative workshops at the Clinical Virology Symposium (CVS) on Monday, May 6 to discover how our experienced team helps commercial customers navigate the complexities involved with bringing new molecular assays to market. Learn how we’ve helped enable the success of our commercial partners, and gain insight into how to access our breadth of custom solutions and unique commercial services.

Location: Westin Savannah Harbor, 1 Resort Dr., Savannah, GA 31421, Grand Ballroom Salon F
Day: Monday, May 6
Time: 1:00–4:30 pm

Schedule:

Overview of current molecular QC yesting for infectious disease and discussion of WHO reference standards, analyte measurement range (AMR), verification and validation

The field of molecular testing for infectious disease has witnessed rapid menu expansion and the advent of new platforms for clinical testing. The growing number of instrument platforms and assays drives the need for accurate and well-qualified quality controls and reference materials for assay development and implementation.

In this workshop we will provide an overview of molecular QC testing for infectious disease and discuss WHO reference standards, how to establish AMR, and how to address verification and validation of assays being brought online.

Speaker:

Linda Cook
Lab Director-Virology
University of Washington

 

Enabling commercialization of robust molecular assays: Tools and technologies to accelerate development

Thermo Fisher Scientific's experienced OEM team enables assay developers to develop robust commercial assays and helps them navigate the complexities and challenges of bringing an assay to market. From sample preparation to assay reagents and instrumentation, we can guide you to the best products for your unique assay. Aside from our off-the-shelf reagent and instruments, we now offer lyophilization compatible reagents and lyophilization services to our commercials partners.

In this workshop, we will discuss the latest advances in lyophilized reagents. Two of our partners, SpeeDx and Vela Diagnostics, will discuss their experiences in developing and commercializing their own infectious disease assays with Thermo Fisher Scientific at their side.

Speakers:

3:00–3:30 pm
Latest advances in lyophilized reagents for real-time PCR assays

Junko Stevens, PhD
Sr. Director, R&D
Thermo Fisher Scientific

3:30–4:00 pm
Enabling Resistance-Guided Therapy for Infectious Diseases
Cassandra Ingles
Manager of Technical Operations, North America
SpeeDx

4:00–4:30 pm
SuperScript IV 1-step RT-PCR: A User Review

Eugene Wee, PhD
Head of Assay Development
Vela Dx

Overview of current molecular QC yesting for infectious disease and discussion of WHO reference standards, analyte measurement range (AMR), verification and validation

The field of molecular testing for infectious disease has witnessed rapid menu expansion and the advent of new platforms for clinical testing. The growing number of instrument platforms and assays drives the need for accurate and well-qualified quality controls and reference materials for assay development and implementation.

In this workshop we will provide an overview of molecular QC testing for infectious disease and discuss WHO reference standards, how to establish AMR, and how to address verification and validation of assays being brought online.

Speaker:

Linda Cook
Lab Director-Virology
University of Washington

 

Enabling commercialization of robust molecular assays: Tools and technologies to accelerate development

Thermo Fisher Scientific's experienced OEM team enables assay developers to develop robust commercial assays and helps them navigate the complexities and challenges of bringing an assay to market. From sample preparation to assay reagents and instrumentation, we can guide you to the best products for your unique assay. Aside from our off-the-shelf reagent and instruments, we now offer lyophilization compatible reagents and lyophilization services to our commercials partners.

In this workshop, we will discuss the latest advances in lyophilized reagents. Two of our partners, SpeeDx and Vela Diagnostics, will discuss their experiences in developing and commercializing their own infectious disease assays with Thermo Fisher Scientific at their side.

Speakers:

3:00–3:30 pm
Latest advances in lyophilized reagents for real-time PCR assays

Junko Stevens, PhD
Sr. Director, R&D
Thermo Fisher Scientific

3:30–4:00 pm
Enabling Resistance-Guided Therapy for Infectious Diseases
Cassandra Ingles
Manager of Technical Operations, North America
SpeeDx

4:00–4:30 pm
SuperScript IV 1-step RT-PCR: A User Review

Eugene Wee, PhD
Head of Assay Development
Vela Dx

Register here:

* Required field

*
*
*
*
*